Australia's most trusted
source of pharma news
Friday, 24 April 2026
Posted 24 April 2026 AM
Boehringer Ingelheim has thrown its weight behind a program to improve access to lung cancer screening in regional and rural Australia.
The pharma has announced a new three-year partnership with Heart of Australia to extend its support to cover the mobile healthcare organisation's National Lung Cancer Screening Program.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.